Company / Current Liabilities
Cocrystal Pharma, Inc. Current Liabilities History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.5M
FY2021
5-year range
$1.4M / $10.8M
FY2017-FY2021
Trend
+13.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities returned to growth in FY2021 after 2 years of decline, reaching $2M.
Based on SEC 10-K filings.
$2M in FY2021.
Improved from $2M to $2M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, current liabilities increased 13.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $1.5M | +13.8% |
| FY2020 | $1.4M | -40.6% |
| FY2019 | $2.3M | -78.9% |
| FY2012 | $10.8M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026